Point-of-Care Molecular Diagnostics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Point-of-Care Molecular Diagnostics Market to 2027 - Global Analysis and Forecasts by Product & Services (Assays & Kits, Instruments/Analyzers and Software & Services), Technology (Real Time PCR, Isothermal Nucleic Acid Amplification Technology (INAAT) and Other Technologies), Application (Sexually Transmitted Diseases, Hospital-Acquired Infections, Oncology, and Other Applications), End User (Physician Offices, Hospital Emergency Departments & Intensive Care Units, Research Institutes, and Other End Users) and Geography

Report Code: TIPRE00003144 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Point-of-care test is conducted on patients at or near a site where a patient encounters the healthcare system. The test has a rapid turnaround time and offers necessary information to conduct further treatment of a patient. The molecular methods of diagnosis are being preferred due to speed, low cost, and ease of use for POC applications.
The ability to diagnose infectious diseases at the site with limited infrastructure is expected to fuel the growth of the point-of-care molecular diagnostics market during the forecast period. Moreover, growing R&D activities for development in molecular diagnostics tests is anticipated to offer significant growth opportunities in the market.
The "Global Point-Of-Care Molecular Diagnostics Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by product & services, technology, application, end user, and geography. The global market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading point-of-care molecular diagnostics market players and offers key trends and opportunities in the market.
The global point-of-care molecular diagnostics market is segmented on the basis of product & services, technology, application, and end user. Based on product & services, the market is segmented as, assays & kits, instruments/analyzers and software & services. On the basis of technology, the market is classified as, real time PCR, isothermal nucleic acid amplification technology (INAAT) and other technologies. The point-of-care molecular diagnostics market is categorized based on applications such as, sexually transmitted diseases, hospital-acquired infections, oncology, and other applications. Based on end user, the point-of-care molecular diagnostics market is segmented as, physician offices, hospital emergency departments & intensive care units, research institutes, and other end users.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global point-of-care molecular diagnostics market based on product & services, technology, application, and end user. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The point-of-care molecular diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the point-of-care molecular diagnostics market in the coming years, owing to rising prevalence of infectious diseases and availability of government initiatives in United States and Canada. Also, Asia Pacific is anticipated to witness steady growth during the forecast period, due to lower availability of large clinical testing spaces as well as the need for clinical tests in nations such as China and India.
The report analyzes factors affecting point-of-care molecular diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the point-of-care molecular diagnostics market in these regions.
The report also includes the profiles of key point-of-care molecular diagnostics companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and technology offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the point-of-care molecular diagnostics market include, Abaxis, Abbott, Binx Health, Inc., bioMérieux SA, Danaher, F. Hoffmann-La Roche Ltd, GenePOC Inc., Mesa Biotech, Quidel Corporation, and Siemens Healthineers among others.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Point-of-Care Molecular Diagnostics Market- By Product & Services
1.3.2. Point-of-Care Molecular Diagnostics Market- By Technology
1.3.3. Point-of-Care Molecular Diagnostics Market- By Application
1.3.4. Point-of-Care Molecular Diagnostics Market- By End User
1.3.5. Point-of-Care Molecular Diagnostics Market- By Region
1.3.5.1. By Country

2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis

5. POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET- GLOBAL ANALYSIS
6.1. POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET - GLOBAL MARKET OVERVIEW
6.2. POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS

7. POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - BY PRODUCT & SERVICES
7.1. OVERVIEW
7.2. PRODUCT & SERVICES MARKET FORECASTS AND ANALYSIS
7.3. ASSAYS & KITS MARKET
7.3.1. Overview
7.3.2. Assays & Kits Market Forecast and Analysis (US$ Mn)
7.4. INSTRUMENTS/ANALYZERS MARKET
7.4.1. Overview
7.4.2. Instruments/Analyzers Forecast and Analysis (US$ Mn)
7.5. SOFTWARE & SERVICES MARKET
7.5.1. Overview
7.5.2. Software & Services Market Forecast and Analysis (US$ Mn)

8. POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - BY TECHNOLOGY
8.1. OVERVIEW
8.2. SERVICES MARKET FORECASTS AND ANALYSIS
8.3. REAL TIME PCR MARKET
8.3.1. Overview
8.3.2. Real Time PCR Market Forecast and Analysis (US$ Mn)
?
8.4. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT) MARKET
8.4.1. Overview
8.4.2. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Forecast and Analysis (US$ Mn)
8.5. OTHER TECHNOLOGIES MARKET
8.5.1. Overview
8.5.2. Other Technologies Market Forecast and Analysis (US$ Mn)

9. POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - BY APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. SEXUALLY TRANSMITTED DISEASES MARKET
9.3.1. Overview
9.3.2. Sexually Transmitted Diseases Market Forecast and Analysis (US$ Mn)
9.4. HOSPITAL-ACQUIRED INFECTIONS MARKET
9.4.1. Overview
9.4.2. Hospital-Acquired Infections Market Forecast and Analysis (US$ Mn)
9.5. ONCOLOGY MARKET
9.5.1. Overview
9.5.2. Oncology Market Forecast and Analysis (US$ Mn)
9.6. OTHER APPLICATIONS MARKET
9.6.1. Overview
9.6.2. Other Applications Market Forecast and Analysis (US$ Mn)

10. POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. PHYSICIAN OFFICES MARKET
10.3.1. Overview
10.3.2. Physician Offices Market Forecast and Analysis (US$ Mn)
10.4. HOSPITAL EMERGENCY DEPARTMENTS & INTENSIVE CARE UNITS MARKET
10.4.1. Overview
10.4.2. Hospital Emergency Departments & Intensive Care Units Market Forecast and Analysis (US$ Mn)
10.5. RESEARCH INSTITUTES MARKET
10.5.1. Overview
10.5.2. Research Institutes Market Forecast and Analysis (US$ Mn)
10.6. OTHER END USERS MARKET
10.6.1. Overview
10.6.2. Other End Users Market Forecast and Analysis (US$ Mn)

11. POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET
11.1.1. North America Point-of-Care Molecular Diagnostics Market Forecasts and Analysis (US$ Mn)
11.1.2. North America Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.1.3. North America Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.1.4. North America Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.1.5. North America Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.1.6. North America Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Country
11.1.7. US Market Overview
11.1.7.1. US Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.1.7.2. US Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.1.7.3. US Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.1.7.4. US Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
?
11.1.8. Canada Market Overview
11.1.8.1. Canada Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.1.8.2. Canada Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.1.8.3. Canada Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.1.8.4. Canada Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.1.9. Mexico Market Overview
11.1.9.1. Mexico Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.1.9.2. Mexico Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.1.9.3. Mexico Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.1.9.4. Mexico Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.2. EUROPE POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET
11.2.1. Europe Point-of-Care Molecular Diagnostics Market Forecasts and Analysis (US$ Mn)
11.2.2. Europe Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.2.3. Europe Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.2.4. Europe Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.2.5. Europe Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.2.6. Europe Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Country
11.2.7. UK Market Overview
11.2.7.1. UK Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.2.7.2. UK Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.2.7.3. UK Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.2.7.4. UK Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
?
11.2.8. Germany Market Overview
11.2.8.1. Germany Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.2.8.2. Germany Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.2.8.3. Germany Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.2.8.4. Germany Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.2.9. France Market Overview
11.2.9.1. France Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.2.9.2. France Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.2.9.3. France Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.2.9.4. France Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.2.10. Spain Market Overview
11.2.10.1. Spain Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.2.10.2. Spain Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.2.10.3. Spain Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.2.10.4. Spain Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.2.11. Italy Market Overview
11.2.11.1. Italy Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.2.11.2. Italy Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.2.11.3. Italy Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.2.11.4. Italy Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
?
11.3. ASIA PACIFIC POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET
11.3.1. Asia Pacific Point-of-Care Molecular Diagnostics Market Forecasts and Analysis (US$ Mn)
11.3.2. Asia Pacific Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.3.3. Asia Pacific Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Type (US$ Mn)
11.3.4. Asia Pacific Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.3.5. Asia Pacific Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.3.6. Asia Pacific Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Country
11.3.7. Japan Market Overview
11.3.7.1. Japan Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.3.7.2. Japan Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.3.7.3. Japan Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.3.7.4. Japan Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.3.8. China Market Overview
11.3.8.1. China Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.3.8.2. China Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.3.8.3. China Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.3.8.4. China Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.3.9. India Market Overview
11.3.9.1. India Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.3.9.2. India Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.3.9.3. India Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.3.9.4. India Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.3.10. Australia Market Overview
11.3.10.1. Australia Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.3.10.2. Australia Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.3.10.3. Australia Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.3.10.4. Australia Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.3.11. South Korea Market Overview
11.3.11.1. South Korea Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.3.11.2. South Korea Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.3.11.3. Australia Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.3.11.4. Australia Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.4. MIDDLE EAST & AFRICA (MEA) POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET
11.4.1. Middle East & Africa (MEA) Point-of-Care Molecular Diagnostics Market Forecasts and Analysis (US$ Mn)
11.4.2. Middle East & Africa (MEA) Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.4.3. Middle East & Africa (MEA) Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.4.4. Middle East & Africa (MEA) Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.4.5. Middle East & Africa (MEA) Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.4.6. Middle East & Africa (MEA) Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Country
11.4.7. South Africa Market Overview
11.4.7.1. South Africa Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.4.7.2. South Africa Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.4.7.3. South Africa Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.4.7.4. South Africa Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.4.8. Saudi Arabia Market Overview
11.4.8.1. Saudi Arabia Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.4.8.2. Saudi Arabia Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.4.8.3. Saudi Arabia Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.4.8.4. Saudi Arabia Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.4.9. UAE Market Overview
11.4.9.1. UAE Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.4.9.2. UAE Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.4.9.3. UAE Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.4.9.4. UAE Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.5. SOUTH AND CENTRAL AMERICA POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET
11.5.1. South and Central America Point-of-Care Molecular Diagnostics Market Forecasts and Analysis (US$ Mn)
11.5.2. South and Central America Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.5.3. South and Central America Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.5.4. South and Central America Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.5.5. South and Central America Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.5.6. South and Central America Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Country
11.5.7. Brazil Market Overview
11.5.7.1. Brazil Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.5.7.2. Brazil Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.5.7.3. Brazil Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.5.7.4. Brazil Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.5.8. Argentina Market Overview
11.5.8.1. Argentina Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Product & Services (US$ Mn)
11.5.8.2. Argentina Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.5.8.3. Argentina Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
11.5.8.4. Argentina Point-of-Care Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)

12. INDUSTRY LANDSCAPE
1.1. ORGANIC GROWTH STRATEGIES
1.1.1. New Product Launches
1.1.2. Marketing & Promotional Activities
1.2. INORGANIC GROWTH STRATEGIES
1.2.1. Partnerships, Collaborations, and Joint Ventures
1.2.2. Mergers & Acquisitions

13. POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, KEY COMPANY PROFILES
13.1. ABAXIS
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Financial Overview
13.1.4. Product/Services Portfolio
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ABBOTT
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Financial Overview
13.2.4. Product/Services Portfolio
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BINX HEALTH, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Financial Overview
13.3.4. Product/Services Portfolio
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BIOMÉRIEUX SA
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Financial Overview
13.4.4. Product/Services Portfolio
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. DANAHER
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Financial Overview
13.5.4. Product/Services Portfolio
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. F. HOFFMANN-LA ROCHE LTD
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Financial Overview
13.6.4. Product/Services Portfolio
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. GENEPOC INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Financial Overview
13.7.4. Product/Services Portfolio
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MESA BIOTECH
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Financial Overview
13.8.4. Product/Services Portfolio
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. QUIDEL CORPORATION
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Financial Overview
13.9.4. Product/Services Portfolio
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SIEMENS HEALTHINEERS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Financial Overview
13.10.4. Product/Services Portfolio
13.10.5. SWOT Analysis
13.10.6. Key Developments
?
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS

NOTE:
• This ToC is tentative in nature and is subject to further refinement during the course of the research study
• The list of company profiles included in this ToC is tentative. Profiles of specific players, if required, shall be added to the report upon request.
• Financials can be provided to the extent of availability in the public domain.
The List of Companies

1. Abaxis
2. Abbott
3. Binx Health, Inc.
4. bioMérieux SA
5. Danaher
6. F. Hoffmann-La Roche Ltd
7. GenePOC Inc.
8. Mesa Biotech
9. Quidel Corporation
10. Siemens Healthineers
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book